CY1110336T1 - Χρηση της αλλοπουρινολης για τη θεραπεια της παλαμοπελματικης ερυθροδυσαισθησιας - Google Patents
Χρηση της αλλοπουρινολης για τη θεραπεια της παλαμοπελματικης ερυθροδυσαισθησιαςInfo
- Publication number
- CY1110336T1 CY1110336T1 CY20101100279T CY101100279T CY1110336T1 CY 1110336 T1 CY1110336 T1 CY 1110336T1 CY 20101100279 T CY20101100279 T CY 20101100279T CY 101100279 T CY101100279 T CY 101100279T CY 1110336 T1 CY1110336 T1 CY 1110336T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- palamophylatic
- allopurinolis
- sleep
- allopurinol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Χρήση της αλλοπουρινόλης ή ενός φαρμακευτικά αποδεκτού άλατος αυτής για τη θεραπεία ή την πρόληψη της παλαμοπελματικής ερυθροδυσαισθησίας που προκαλείται από χημειοθεραπεία. Η αλλοπουρινόλη ή το άλας της χορηγείται τοπικά στις περιοχές που έχουν προσβληθεί, τις παλάμες και τα πέλματα, κατά προτίμηση στη μορφή μιας κρέμας.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06011432A EP1862166A1 (en) | 2006-06-01 | 2006-06-01 | Use of allopurinol for the treatment of palmar plantar erythrodysesthesia |
EP07107744 | 2007-05-08 | ||
EP07729768A EP2035006B1 (en) | 2006-06-01 | 2007-05-31 | Use of allopurinol for the treatment of palmar plantar erythrodysesthesia |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1110336T1 true CY1110336T1 (el) | 2015-01-14 |
Family
ID=38512579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20101100279T CY1110336T1 (el) | 2006-06-01 | 2010-03-23 | Χρηση της αλλοπουρινολης για τη θεραπεια της παλαμοπελματικης ερυθροδυσαισθησιας |
Country Status (21)
Country | Link |
---|---|
US (3) | US7973046B2 (el) |
EP (1) | EP2035006B1 (el) |
JP (3) | JP5028480B2 (el) |
KR (1) | KR101471022B1 (el) |
AT (1) | ATE457729T1 (el) |
AU (1) | AU2007267069B2 (el) |
CA (1) | CA2654270C (el) |
CY (1) | CY1110336T1 (el) |
DE (1) | DE602007004849D1 (el) |
DK (1) | DK2035006T3 (el) |
ES (1) | ES2341379T3 (el) |
HR (1) | HRP20100210T1 (el) |
IL (1) | IL195472A (el) |
MX (1) | MX2008015266A (el) |
NZ (1) | NZ573248A (el) |
PL (1) | PL2035006T3 (el) |
PT (1) | PT2035006E (el) |
RS (1) | RS51252B (el) |
RU (1) | RU2438673C2 (el) |
SI (1) | SI2035006T1 (el) |
WO (1) | WO2007138103A1 (el) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2246057A1 (en) * | 2009-04-29 | 2010-11-03 | Nobera Pharma, S.L. | Use of allopurinol for the treatment of hand foot skin reaction |
CN102648279B (zh) | 2009-10-16 | 2015-11-25 | 杜克大学 | 用于治疗药物诱发的手足综合征的组合物与方法 |
EP2368549A1 (en) | 2010-03-25 | 2011-09-28 | BioAlliance Pharma | Treating hand-foot syndrome and related pathologies using clonidine or its derivatives |
JP4983989B2 (ja) * | 2010-03-31 | 2012-07-25 | 小野薬品工業株式会社 | 手足症候群の予防および治療剤 |
US8729056B2 (en) | 2010-03-31 | 2014-05-20 | Ono Pharmaceutical Co., Ltd. | Preventive and/or therapeutic agent of hand-foot syndrome |
JP4761000B1 (ja) * | 2010-11-08 | 2011-08-31 | 小野薬品工業株式会社 | 手足症候群の予防および/または治療剤 |
US9259343B2 (en) | 2012-07-06 | 2016-02-16 | Newman Technologies LLC | Device for mitigating plantar fasciitis |
EP2712613B1 (en) * | 2012-09-28 | 2017-02-08 | Pharmadab d.o.o. | Vitamin K1 and uses thereof |
JP2019512536A (ja) * | 2016-03-28 | 2019-05-16 | ヴィダック ファーマ リミテッド | 局所投与のための安定な医薬組成物およびその使用 |
WO2019114705A1 (zh) | 2017-12-13 | 2019-06-20 | 上海小午医药科技有限公司 | 一种用于预防或治疗与egfr被抑制相关疾病的方法 |
KR20200144116A (ko) | 2018-04-16 | 2020-12-28 | 온퀄리티 파마슈티컬스 차이나 리미티드 | 암 치료의 부작용을 예방하거나 치료하기 위한 방법 |
RU2722396C2 (ru) * | 2018-07-11 | 2020-05-29 | Федеральное государственное бюджетное учреждение дополнительного профессионального образования "Центральная государственная медицинская академия" Управления делами Президента Российской Федерации (ФГБУ ДПО "ЦГМА") | Способ лечения пальмарно-плантарной эритродизестезии |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3011A (en) * | 1843-03-21 | Improvement in water-wheels | ||
ES2037672T3 (es) | 1987-02-13 | 1993-07-01 | Pharm-Allergan Gmbh | Utilizacion de pteridinas y/o purinas o de un inhibidor de xantinoxidasa para la fabricacion de un medicamento para el tratamiento de enfermedades degenerativas de la retina condicionadas geneticamente. |
JPH03106817A (ja) | 1989-09-20 | 1991-05-07 | Nippon Kayaku Co Ltd | アロプリノール製剤 |
JPH066700A (ja) | 1992-06-22 | 1994-01-14 | Fujitsu General Ltd | ハイビジョン受像機 |
GB9218711D0 (en) | 1992-09-04 | 1992-10-21 | Salim Aws S M | Skin cancer treatment |
WO1994005293A1 (en) | 1992-09-04 | 1994-03-17 | Aws Shakir Mustafa Salim | Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol |
JP3106817B2 (ja) | 1993-11-02 | 2000-11-06 | 富士電機株式会社 | 漏電遮断器 |
US6284234B1 (en) * | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
US6060083A (en) | 1999-04-01 | 2000-05-09 | Topical Technologies, Inc. | Topical DMSO treatment for palmar-plantar erythrodysethesia |
EP1292265B1 (de) * | 2000-06-20 | 2007-03-21 | Henkel Kommanditgesellschaft auf Aktien | Verwendung von Vitamin B6-Derivaten zur Haarstrukturverbesserung |
DE60117043T2 (de) | 2000-11-22 | 2006-07-13 | Rxkinetix, Inc., Louisville | Behandlung von mukositis |
US7544348B2 (en) | 2001-02-15 | 2009-06-09 | Access Pharmaceuticals, Inc. | Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
DK1455888T3 (da) * | 2001-08-29 | 2009-08-24 | Pharmakodex Ltd | Topisk indgivelsesindretning |
US20030157191A1 (en) | 2001-11-29 | 2003-08-21 | Sound Pharmaceuticals Incorporated | Methods and compositions for ameliorating the undesirable effects of chemotherapy |
DE10200578A1 (de) * | 2002-01-09 | 2003-07-10 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme |
US6979688B2 (en) * | 2002-02-12 | 2005-12-27 | Ford John P | Treatment method against side-effects of chemotherapy |
US20040214215A1 (en) * | 2003-03-07 | 2004-10-28 | Yu Ruey J. | Bioavailability and improved delivery of alkaline pharmaceutical drugs |
CA2528359A1 (en) | 2003-06-11 | 2004-12-23 | Novacea, Inc. | Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
AU2004247108A1 (en) | 2003-06-11 | 2004-12-23 | Novacea, Inc | Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents |
US20050148910A1 (en) | 2003-12-24 | 2005-07-07 | Gregory Skover | Apparatus having a skin-contactable element containing an agent |
AU2005218539A1 (en) * | 2004-03-01 | 2005-09-15 | Lumen Therapeutics, Llc | Compositions and methods for treating diseases |
JP4405326B2 (ja) | 2004-06-28 | 2010-01-27 | 株式会社東芝 | ランドリー機器 |
WO2006030437A2 (en) * | 2004-09-17 | 2006-03-23 | Biomas Ltd. | Novel tellurium compounds and their use as immunomodulators |
-
2007
- 2007-05-31 PT PT07729768T patent/PT2035006E/pt unknown
- 2007-05-31 AT AT07729768T patent/ATE457729T1/de active
- 2007-05-31 EP EP07729768A patent/EP2035006B1/en active Active
- 2007-05-31 RU RU2008152341/15A patent/RU2438673C2/ru not_active IP Right Cessation
- 2007-05-31 WO PCT/EP2007/055367 patent/WO2007138103A1/en active Application Filing
- 2007-05-31 RS RSP-2010/0163A patent/RS51252B/sr unknown
- 2007-05-31 JP JP2009512609A patent/JP5028480B2/ja not_active Expired - Fee Related
- 2007-05-31 MX MX2008015266A patent/MX2008015266A/es active IP Right Grant
- 2007-05-31 PL PL07729768T patent/PL2035006T3/pl unknown
- 2007-05-31 AU AU2007267069A patent/AU2007267069B2/en not_active Ceased
- 2007-05-31 CA CA2654270A patent/CA2654270C/en not_active Expired - Fee Related
- 2007-05-31 DK DK07729768.7T patent/DK2035006T3/da active
- 2007-05-31 NZ NZ573248A patent/NZ573248A/en not_active IP Right Cessation
- 2007-05-31 ES ES07729768T patent/ES2341379T3/es active Active
- 2007-05-31 SI SI200730172T patent/SI2035006T1/sl unknown
- 2007-05-31 DE DE602007004849T patent/DE602007004849D1/de active Active
- 2007-05-31 US US12/227,807 patent/US7973046B2/en not_active Expired - Fee Related
-
2008
- 2008-11-24 IL IL195472A patent/IL195472A/en not_active IP Right Cessation
- 2008-12-31 KR KR1020087032168A patent/KR101471022B1/ko not_active IP Right Cessation
-
2010
- 2010-03-23 CY CY20101100279T patent/CY1110336T1/el unknown
- 2010-04-14 HR HR20100210T patent/HRP20100210T1/hr unknown
-
2011
- 2011-05-24 US US13/114,768 patent/US8557829B2/en not_active Expired - Fee Related
-
2012
- 2012-05-23 JP JP2012118062A patent/JP5389980B2/ja not_active Expired - Fee Related
-
2013
- 2013-09-09 US US14/021,723 patent/US20140011820A1/en not_active Abandoned
- 2013-10-09 JP JP2013211700A patent/JP2014028851A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1110336T1 (el) | Χρηση της αλλοπουρινολης για τη θεραπεια της παλαμοπελματικης ερυθροδυσαισθησιας | |
EA202091303A3 (ru) | Композиция ингибитора jak для местного применения | |
HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
MY148688A (en) | 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors | |
CL2013001136A1 (es) | Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional. | |
ECSP088902A (es) | Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios | |
WO2009114810A3 (en) | Use of ellagitannins as inhibitors of bacterial quorum sensing | |
CU20130069A7 (es) | Derivados de 2,3-dihidroimidazo[1,2-c] quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermeddes asociadas a la angiogénesis | |
EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
UY29127A1 (es) | Nuevos derivados de pirimidina y su uso | |
NZ700924A (en) | Dosage regimen for a pi-3 kinase inhibitor | |
MX2009005798A (es) | Recuperacion de apoplejia. | |
CR10410A (es) | Carboxamidas sustituidas. | |
WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
MX2011011529A (es) | Uso de alopurinol para el tratamiento de la reaccion cutanea en manos-pies. | |
WO2006102899A3 (en) | Oxaprozin or closely related compound for the treatment and prevention of | |
DK1732551T3 (da) | Perhexilin til behandling af kronisk hjertesvigt | |
DE602005023742D1 (de) | Formulierung von 3-amino-8-(1-piperazinyl)-2h-1benzopyran-2-on mit verzögerter freisetzung | |
BRPI0918593A2 (pt) | composição farmacêutica para uso no tratamento de infecções transmitidas sexualmente | |
CY1114601T1 (el) | Χρηση της αλλοπουρινολης για την αγωγη της δερματικης αντιδρασης χειρος-ποδος | |
EA200970292A1 (ru) | Производные 5-тиоксилопиранозы и их применение в терапии | |
DOP2005000177A (es) | Nuevos derivados de pirimidina y su uso | |
CY1110563T1 (el) | Παραγωγο του ισοξαζολικου οξεος για την ανακουφιση νευροπαθητικου πονου |